Characterization of high mobility group protein binding to cisplatin-damaged DNA
Open Access
- 16 November 1992
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 188 (3) , 1286-1294
- https://doi.org/10.1016/0006-291x(92)91371-v
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Specific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug CisplatinScience, 1992
- Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II)Biochemical Journal, 1991
- Molecular mechanisms of drug resistanceBiochemical Journal, 1990
- Treatment of testicular cancer: a new and improved model.Journal of Clinical Oncology, 1990
- High mobility group proteins 1 and 2 function as general class II transcription factorsBiochemistry, 1990
- Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatinBiochemistry, 1990
- Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical dataInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNABiochemistry, 1986
- Nonhistone proteins HMG1and HMG2unwind DNA double helixNucleic Acids Research, 1979
- Nonhistone Proteins HMG 1 and HMG 2 Change the DNA Helical StructureScience, 1978